Location History:
- Carrboro, NC (US) (2011)
- Issaquah, WA (US) (2019 - 2024)
Company Filing History:
Years Active: 2011-2024
Title: The Innovative Journey of David Evans Roth
Introduction
David Evans Roth, an accomplished inventor based in Issaquah, WA, has made significant contributions to the field of drug delivery systems. With five patents to his name, Roth's work focuses on improving methods that facilitate the delivery of bioactive agents in innovative ways.
Latest Patents
Roth's latest patents showcase a groundbreaking two-part bioactive agent delivery system. This system comprises a disposable part featuring an agent reservoir, a bolus chamber, and an agent outlet, along with a valve that alternates between directing bioactive agents from the reservoir to the bolus chamber and then to the outlet. A reusable part includes essential components such as a valve driver, a power source, and sophisticated control electronics designed to manage the delivery mechanism. Furthermore, the system incorporates a spring that ensures the agent reservoir remains pressurized, enhancing the efficacy of the bioactive agent delivery.
Career Highlights
Throughout his career, David Roth has been associated with notable companies such as Morningside Venture Investments Limited and Chrono Therapeutics Inc. His work in these organizations has allowed him to leverage his innovative mindset and technical expertise, leading to advancements in drug delivery technologies.
Collaborations
Roth has collaborated with esteemed professionals in his field, including his coworkers Jennifer Darmour and Jenny E. Hapgood. These partnerships have fostered an environment of shared knowledge and innovation, further enhancing the development of effective drug delivery systems.
Conclusion
David Evans Roth remains a prominent figure in the realm of innovative drug delivery technologies. His patented systems not only reflect his dedication to improving healthcare solutions but also underscore the potential of his inventions to transform the way medical treatments are administered. Through his ongoing work, Roth continues to pave the way for future advancements in the field.